搜索临床试验以:PvP002 的最大可行剂量 (MFD)
总计60个结果
-
Millennium Pharmaceuticals, Inc.完全的
-
Dawonmedax Co., Ltd.招聘中
-
University Hospital Schleswig-Holstein招聘中
-
Immunocore Ltd招聘中
-
Medical College of WisconsinMiltenyi Biomedicine GmbH主动,不招人
-
Tongji UniversityShanghai Pharmaceuticals Holding Co., Ltd主动,不招人
-
AIO-Studien-gGmbHDeutsche Krebshilfe e.V., Bonn (Germany)招聘中
-
Medical College of WisconsinBarbara Ann Karmanos Cancer Institute; Cornerstone Pharmaceuticals招聘中
-
Boehringer IngelheimEli Lilly and Company完全的
-
AstraZenecaMedImmune LLC完全的
-
MAXVAX Biotechnology Limited Liability CompanyHenan Center for Disease Control and Prevention主动,不招人
-
MedicagoHealth Sciences Centre, Winnipeg, Manitoba; Syneos Health; Public Health Agency of Canada (PHAC)完全的
-
Medicines Development for Global HealthImperial College London; Phillip T. and Susan M. Ragon Foundation终止
-
MedicagoMcGill University Health Centre/Research Institute of the McGill University Health Centre; Syneos...完全的
-
Indiana UniversityNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Auro Vaccines LLCUnited States Department of Defense; Accelovance完全的
-
Brown UniversityRhode Island Hospital; Memorial Hospital of Rhode Island; Lifespan完全的
-
Jonsson Comprehensive Cancer CenterPfizer完全的
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Assistance Publique - Hôpitaux de ParisAction Research Group终止
-
Pacira Pharmaceuticals, Inc完全的
-
University of ManitobaCanadian Institutes of Health Research (CIHR); BioMark Technologies Inc.完全的
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCUF Tejo Hospital; Orthoapnea尚未招聘
-
Sound Pharmaceuticals, IncorporatedMedical University of South Carolina; Cystic Fibrosis Foundation邀请报名
-
The University of Hong KongCenters for Disease Control and Prevention主动,不招人
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)完全的
-
Charite University, Berlin, GermanyThe Volkswagen Foundation完全的